RAPT is closing two Phase II trials for Rapt’s lead candidate, zelnecirnon, thre...
The positive Phase I/II data has supported a RMAT designation from the FDA and a...
The FDA has given an IND approval for WestGene’s mRNA therapeutic cancer vaccine...
Discover key insights into the selection of oral solid dosage manufacturing comp...
The US FDA has granted fast track designation for iECURE’s ECUR-506 for the trea...
AstraZeneca has begun the global withdrawal of its Covid-19 vaccine Vaxzevria, c...
We look at the top six most important trends in pharmaceutical milling and how t...
BioVersys and GSK have announced the expansion of their partnership to expedite ...
TerSera has obtained Health Canada approval for ZOLADEX LA 10.8mg to manage oest...
The companies will utilise Broken String’s DNA break mapping platform Induce-seq...
A new study has further supported psilocybin's potential to treat depression, wh...
Coinfections can complicate disease management and hence continued surveillance ...
At the London Biotechnology Show, Microsoft’s senior director of life sciences d...
Zenas signed a licencing deal for Asia-Pacific territories for the bispecific an...
Cipla and Glenmark Pharmaceuticals are recalling specific products from the US m...
Lantern Pharma has entered into a partnership with Oregon for optimising the dev...
